1139Tip IDE196 (darovasertib) in Combination with Crizotinib Versus Investigator’s Choice of Treatment As First-Line Therapy in HLA-A2 Negative Metastatic Uveal Melanoma
Annals of Oncology(2024)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined